Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort
Article
[키워드] 95% CI
absorbance
Ad26.COV2.S
age
Analysis
Anti-RBD IgG
antibody
antibody level
Antibody Response
association
binding domain
blood sample
BNT162b2
booster
booster doses
Breakthrough infection
calculated
calibrator
COVID-19
COVID-19 vaccination
COVID-19 vaccine
cross-sectional
Delta
demonstrated
effective
home
Humoral immunity
IgG
IgG level
increased risk
individual
Infection
Level
median
multivariate
no difference
Nursing
omicron
outcome
participant
persistence
populations
Potential
protective role
regression modeling
RNA-1273
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 surveillance
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
SARS-CoV-2 variant
Sex
significantly higher
significantly lower
specimen
subsequent
the mean
vaccination
Vaccine
Virginia
were assessed
West
white
[DOI] 10.1001/jamanetworkopen.2022.31334 PMC 바로가기
[DOI] 10.1001/jamanetworkopen.2022.31334 PMC 바로가기